Cover Image

Ixekizumab for the treatment of acrodermatitis continua of hallopeau and inverse psoriasis

Saved in:

Bibliographic Details
Main Authors:	Rui Yuan Xia (Author), Jian Liu (Author), Dan Dan Chen (Author), Zi Yue Diao (Author), Ya Mei Gao (Author), Zhi Qiang Yin (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Acrodermatitis continua Hallopeau
by: Julia Nowowiejska, et al.
Published: (2021)

Pustular psoriasis of pregnancy with acrodermatitis continua of hallopeau
by: Akanksha Shah, et al.
Published: (2016)

Acrodermatitis continua of hallopeau evolving into generalised pustular psoriasis
by: Poovanur SS Ranugha, et al.
Published: (2013)

Dermoscopy of acrodermatitis continua of Hallopeau
by: Setu Mittal, et al.
Published: (2023)

Acrodermatitis continua of Hallopeau and geographic tongue are variants of pustular psoriasis
by: Muriel Sadlier, MB, BMedSc, MRCPI
Published: (2018)

ACRODERMATITIS CONTINUA SUPPURATIVA HALLOPEAU IN COMBINATION WITH LOCALIZED PSORIASIS VULGARIS
by: E. V. Sokolovskiy, et al.
Published: (2017)

Acrodermatitis continua of Hallopeau: clinical perspectives
by: Smith MP, et al.
Published: (2019)

Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab
by: Luigi Gargiulo, et al.
Published: (2023)

Acrodermatitis Continua of Hallopeau Successfully Treated With Bimekizumab
by: Andrea Pagliara, et al.
Published: (2024)

Clinico-pathological and dermoscopic features in acrodermatitis continua of hallopeau
by: Gargi Taneja, et al.
Published: (2021)

Acrodermatitis continua of Hallopeau with psoriatic arthritis treated with biologics and apremilast
by: Shohei Igari, et al.
Published: (2023)

Acrodermatitis continua of hallopeau: aggravating factors and treatment outcomes of 96 patients
by: Liyan Yuan, et al.
Published: (2024)

Acrodermatitis continua de Hallopeau y el fenómeno de Koebner
by: C. Sousa, et al.
Published: (2021)

Successful treatment of acrodermatitis continua of hallopeau with an anti-IL-17A agent
by: Sae Inoue, et al.
Published: (2021)

Lingual Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Successfully Treated with Adalimumab: A Rare Case Report and Review of Oral Psoriasis
by: Sarah J.J. Touyz, et al.
Published: (2018)

Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review
by: Shi L, et al.
Published: (2023)

Treatment and molecular profiling of acrodermatitis continua of Hallopeau during pregnancy using targeted therapy
by: Sara Al-Khawaga, MD, et al.
Published: (2021)

Successful treatment of acrodermatitis continua of Hallopeau by TYK2 inhibitor with every other day
by: Yuji Kan, et al.
Published: (2024)

Acrodermatitis Continua of Hallopeau with Bone Resorption in an 8-Year-Old Patient: A Case Report
by: May Alorainy, et al.
Published: (2017)

Acrodermatitis continua of Hallopeau in an elderly patient successfully and rapidly treated with risankizumab: a case report
by: Diego Orsini, et al.
Published: (2023)

Acrodermatitis of Hallopeau and erosive oral mucositis successfully treated with secukinumab
by: Jennifer A. Baron, MD
Published: (2017)

Erythrodermic psoriasis after discontinuation of ixekizumab
by: Kathryn Anne Potter, MD, et al.
Published: (2018)

Verrucous inverse psoriasis: A novel variant of psoriasis
by: Hsuan-An Su, et al.
Published: (2023)

Toxoplasmosis in a patient receiving ixekizumab for psoriasis
by: Yolanka Lobo, BPhysio, MBBS, et al.
Published: (2020)

Pemphigus vegetans of hallopeau
by: Nanda Soni, et al.
Published: (2005)

The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab
by: Sara Ghoneim, et al.
Published: (2017)

A case of scalp psoriasis resistant to ixekizumab treated with bimekizumab
by: Matteo Megna, MD, et al.
Published: (2023)

Emerging targeted therapies for plaque psoriasis – impact of ixekizumab
by: Kazemi T, et al.
Published: (2017)

Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
by: Ren V, et al.
Published: (2013)

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
by: Sekhon S, et al.
Published: (2017)

Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
by: Hanley TL, et al.
Published: (2017)

Acrodermatitis enteropática
by: María Elena Martínez-Bustamante, et al.
Published: (2017)

Ixekizumab
by: İlgen Ertam Sağduyu
Published: (2022)

Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
by: Timothy Fitzgerald, et al.
Published: (2023)

Long-term management of pediatric psoriasis with ixekizumab: a case report
by: Diego Orsini, et al.
Published: (2023)

Severe Generalized Pustular Psoriasis Successfully Treated with Ixekizumab: A Case Report
by: Martina Burlando, et al.
Published: (2022)

Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis
by: Kim Papp, et al.
Published: (2022)

Hair whitening in a patient with psoriasis on adalimumab reversed after switching to ixekizumab
by: Annunziata Raimondo, MD, et al.
Published: (2021)

Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity
by: April W. Armstrong, et al.
Published: (2024)

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain
by: Johansson E, et al.
Published: (2018)